Literature DB >> 12195356

Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings.

Daniel Ajzenberg1, Nadine Cogné, Luc Paris, Marie-Hélène Bessières, Philippe Thulliez, Denis Filisetti, Hervé Pelloux, Pierre Marty, Marie-Laure Dardé.   

Abstract

To study the influence of Toxoplasma gondii genotypes on the severity of human congenital toxoplasmosis (asymptomatic, benign, or severe infection or newborn or fetal death), 8 microsatellite markers were used to analyze 86 T. gondii isolates collected from patients with congenital toxoplasmosis. Seventy-four different genotypes were detected, some identical genotypes originating probably from the same source of contamination. The 3 less polymorphic microsatellite markers associated with 6 isoenzymatic markers allowed a classification of isolates into the 3 classical types and detected atypical genotypes. Whatever the clinical findings, type II isolates were largely predominant (84.88% in the whole collection and 96.49% in 57 consecutive cases). Type I and atypical isolates were not found in asymptomatic or benign congenital toxoplasmosis. However, in 4 cases in which children were not infected despite isolation of T. gondii from placenta, only type I isolates were found.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195356     DOI: 10.1086/342663

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  118 in total

1.  Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana.

Authors:  B Carme; F Bissuel; D Ajzenberg; R Bouyne; C Aznar; M Demar; S Bichat; D Louvel; A M Bourbigot; C Peneau; P Neron; M L Dardé
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Immunological comparison of 124 isolates of Toxoplasma gondii.

Authors:  D D Smith; J K Frenkel
Journal:  Parasitol Res       Date:  2003-09-16       Impact factor: 2.289

3.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

4.  Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages.

Authors:  Chunlei Su; Asis Khan; Peng Zhou; Debashree Majumdar; Daniel Ajzenberg; Marie-Laure Dardé; Xing-Quan Zhu; James W Ajioka; Benjamin M Rosenthal; Jitender P Dubey; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

5.  Direct genotypic characterization of Toxoplasma gondii strains associated with congenital toxoplasmosis in Tunisia (North Africa).

Authors:  Sonia Boughattas; Rym Ben-Abdallah; Emna Siala; Olfa Souissi; Karim Aoun; Aïda Bouratbine
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

6.  Genotyping of Toxoplasma gondii isolates with 15 microsatellite markers in a single multiplex PCR assay.

Authors:  Daniel Ajzenberg; Frédéric Collinet; Aurélien Mercier; Philippe Vignoles; Marie-Laure Dardé
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

7.  Multiplex PCR for typing strains of Toxoplasma gondii.

Authors:  Daniel Ajzenberg; Aurélien Dumètre; Marie-Laure Dardé
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.

Authors:  Laurel Rodgers; Xisheng Wang; Xiangshu Wen; Bradley Dunford; Renee Miller; Yasuhiro Suzuki
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

9.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

10.  Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents.

Authors:  Susana Sousa; Daniel Ajzenberg; Manuel Vilanova; José Costa; Marie-Laure Dardé
Journal:  Clin Vaccine Immunol       Date:  2008-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.